We serve 2-Fluoro-5-formylbenzoic acid CAS:550363-85-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 2-Fluoro-5-formylbenzoic acid
CAS.NO: 550363-85-4
Synonyms:
fluoroformylbenzoicacid
2-fluoranyl-5-methanoyl-benzoic acid
2-fluoro-5-formyl-benzoic acid
Molecular Formula:C8H5FO3
Molecular Weight: 168.12200
Physical and Chemical Properties:
Density: 1.427g / cm3
Boiling point: 330.902ºC at 760 mmHg
Melting point: 174.5-178.5ºC
Flash point: 153.924ºC
Refractive index: 1.591
Specification:
Appearance:Pale brown solid
Purity:≥98%
Impurity: ≤0.5%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Olaparib CAS:763113-22-0
Contact us for information like 2-Fluoro-5-formylbenzoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-fluoro-5-formyl-benzoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-fluoranyl-5-methanoyl-benzoic acid Use and application,fluoroformylbenzoicacid technical grade,usp/ep/jp grade.
Related News: However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period.Methyl linoleate manufacturer Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).2-Methyl-3-trifluoromethylaniline supplier Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).1,3-Dichloro-4-fluorobenzene vendor Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).The World Health Organisation (WHO) describes coronaviruses as a large family of viruses ranging from the common cold to more severe diseases such as Severe Acute Respiratory Syndrome (SARS), which killed nearly 800 people globally during a 2002/03 outbreak that also started in China.
